TrialMaster EDC and Acuity Analytics Selected for Major Clinical Study

A large pharmaceutical company in China will conduct a multisite clinical study using TrialMaster® EDC and Acuity Analytics, from OmniComm Systems, Inc. This company will utilize OmniComm's eClinical solutions in this multicenter, randomized, double-blind, placebo-controlled clinical trial of a treatment for a well-known cognitive disorder.

Read the full release here.